Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU medtech reg: Global and EU guidance docs still offer more sustainable way forward

This article was originally published in Clinica

Executive Summary

Is the proposed introduction of the “scrutiny procedure” a sign that EU regulators have lost faith in the wealth of EU and global guidance documents that have painstakingly been put together over the last decade? Emmett Devereux, director of quality and regulatory affairs at Cook Medical, reflects on what he considers to be an equally convincing way forward to regulate medical devices, but without the need to introduce any substantially new and potentially disruptive and economically crippling measures

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099629

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel